Correlation Between Monopar Therapeutics and WALMART

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and WALMART at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and WALMART into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and WALMART INC 3625, you can compare the effects of market volatilities on Monopar Therapeutics and WALMART and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of WALMART. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and WALMART.

Diversification Opportunities for Monopar Therapeutics and WALMART

0.24
  Correlation Coefficient

Modest diversification

The 3 months correlation between Monopar and WALMART is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and WALMART INC 3625 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WALMART INC 3625 and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with WALMART. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WALMART INC 3625 has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and WALMART go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and WALMART

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 4.48 times more return on investment than WALMART. However, Monopar Therapeutics is 4.48 times more volatile than WALMART INC 3625. It trades about 0.33 of its potential returns per unit of risk. WALMART INC 3625 is currently generating about 0.26 per unit of risk. If you would invest  2,200  in Monopar Therapeutics on November 1, 2024 and sell it today you would earn a total of  1,560  from holding Monopar Therapeutics or generate 70.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy85.0%
ValuesDaily Returns

Monopar Therapeutics  vs.  WALMART INC 3625

 Performance 
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
WALMART INC 3625 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in WALMART INC 3625 are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, WALMART may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Monopar Therapeutics and WALMART Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monopar Therapeutics and WALMART

The main advantage of trading using opposite Monopar Therapeutics and WALMART positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, WALMART can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WALMART will offset losses from the drop in WALMART's long position.
The idea behind Monopar Therapeutics and WALMART INC 3625 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Transaction History
View history of all your transactions and understand their impact on performance